Sippy Kaur

New York University — United States

Biochemistry, Genetics and Molecular Biology · Life Sciences

20h-index2.5kcitations100works0.02yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Cancer Genomics and Diagnostics(29), MicroRNA in disease regulation(27), Cancer-related molecular mechanisms research(23), Cancer, Hypoxia, and Metabolism(22), Molecular Biology Techniques and Applications(21)

Publications99 total

588 Defining SOX2 as a pharmacologically targetable squamous carcinogenesis promoter
Journal of Investigative Dermatology·2024Open Access
Supplementary Table 2 from MicroRNA Microarray Identifies <i>Let-7i</i> as a Novel Biomarker and Therapeutic Target in Human Epithelial Ovarian Cancer
2023Open Access
Data from A Combined Array-Based Comparative Genomic Hybridization and Functional Library Screening Approach Identifies mir-30d As an Oncomir in Cancer
2023Open Access
Supplementary Figure 5 from Double-Negative Feedback Loop between Reprogramming Factor LIN28 and microRNA <i>let-7</i> Regulates Aldehyde Dehydrogenase 1–Positive Cancer Stem Cells
2023Open Access
Supplementary Table 3 from A Combined Array-Based Comparative Genomic Hybridization and Functional Library Screening Approach Identifies mir-30d As an Oncomir in Cancer
2023Open Access
Supplementary Table 1 from MicroRNA Microarray Identifies <i>Let-7i</i> as a Novel Biomarker and Therapeutic Target in Human Epithelial Ovarian Cancer
2023Open Access
Supplementary Figure 1 from Double-Negative Feedback Loop between Reprogramming Factor LIN28 and microRNA <i>let-7</i> Regulates Aldehyde Dehydrogenase 1–Positive Cancer Stem Cells
2023Open Access
Supplementary Table 4 from A Combined Array-Based Comparative Genomic Hybridization and Functional Library Screening Approach Identifies mir-30d As an Oncomir in Cancer
2023Open Access
Supplementary Methods from Double-Negative Feedback Loop between Reprogramming Factor LIN28 and microRNA <i>let-7</i> Regulates Aldehyde Dehydrogenase 1–Positive Cancer Stem Cells
2023Open Access
Supplementary Table 2 from A Combined Array-Based Comparative Genomic Hybridization and Functional Library Screening Approach Identifies mir-30d As an Oncomir in Cancer
2023Open Access
Supplementary Figure 6 from Double-Negative Feedback Loop between Reprogramming Factor LIN28 and microRNA <i>let-7</i> Regulates Aldehyde Dehydrogenase 1–Positive Cancer Stem Cells
2023Open Access
Supplementary Figure 1 from A Combined Array-Based Comparative Genomic Hybridization and Functional Library Screening Approach Identifies mir-30d As an Oncomir in Cancer
2023Open Access
Supplementary Figure Legends 1-3 from A Combined Array-Based Comparative Genomic Hybridization and Functional Library Screening Approach Identifies mir-30d As an Oncomir in Cancer
2023Open Access
Data from MicroRNA Microarray Identifies <i>Let-7i</i> as a Novel Biomarker and Therapeutic Target in Human Epithelial Ovarian Cancer
2023Open Access
Supplementary Methods from Double-Negative Feedback Loop between Reprogramming Factor LIN28 and microRNA <i>let-7</i> Regulates Aldehyde Dehydrogenase 1–Positive Cancer Stem Cells
2023Open Access
Supplementary Figure 3 from Double-Negative Feedback Loop between Reprogramming Factor LIN28 and microRNA <i>let-7</i> Regulates Aldehyde Dehydrogenase 1–Positive Cancer Stem Cells
2023Open Access
Supplementary Table 1 from MicroRNA Microarray Identifies <i>Let-7i</i> as a Novel Biomarker and Therapeutic Target in Human Epithelial Ovarian Cancer
2023Open Access
Data from MicroRNA Microarray Identifies <i>Let-7i</i> as a Novel Biomarker and Therapeutic Target in Human Epithelial Ovarian Cancer
2023Open Access
Supplementary Figure Legends 1-3 from A Combined Array-Based Comparative Genomic Hybridization and Functional Library Screening Approach Identifies mir-30d As an Oncomir in Cancer
2023Open Access
Supplementary Figure 2 from A Combined Array-Based Comparative Genomic Hybridization and Functional Library Screening Approach Identifies mir-30d As an Oncomir in Cancer
2023Open Access
page 1 of 5Next →

Frequent Co-authors

Ralf Bützow(26), Heini Lassus(23), Shun Liang(17), George Coukos(17), Dionyssios Katsaros(16), Arto Leminen(12), Païvi Peltomäki(12), Joel Greshock(11), Qihong Huang(11), Riitta Seppänen‐Kaijansinkko(11), Bettina Mannerström(10), Xiaomin Zhong(10), Barbara L. Weber(9), Jukka‐Pekka Mecklin(9), Laura Renkonen‐Sinisalo(8), Lin Zhang(7), Heikki Järvinen(7), Kathleen T. Montone(6), Lin Zhang(6), Sakari Knuutila(6)